JPS60215687A - Production of pyrazolo(1,5-b)(1,2,4)triazole derivative - Google Patents
Production of pyrazolo(1,5-b)(1,2,4)triazole derivativeInfo
- Publication number
- JPS60215687A JPS60215687A JP7014684A JP7014684A JPS60215687A JP S60215687 A JPS60215687 A JP S60215687A JP 7014684 A JP7014684 A JP 7014684A JP 7014684 A JP7014684 A JP 7014684A JP S60215687 A JPS60215687 A JP S60215687A
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- pyrazolo
- compound represented
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- BXUURYQQDJGIGA-UHFFFAOYSA-N N1C=NN2N=CC=C21 Chemical class N1C=NN2N=CC=C21 BXUURYQQDJGIGA-UHFFFAOYSA-N 0.000 title description 2
- -1 imide ester Chemical class 0.000 claims abstract description 122
- 150000001875 compounds Chemical class 0.000 claims abstract description 34
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 17
- 125000003118 aryl group Chemical group 0.000 claims abstract description 11
- 230000001590 oxidative effect Effects 0.000 claims abstract description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
- 238000006482 condensation reaction Methods 0.000 claims description 2
- MZWDAEVXPZRJTQ-WUXMJOGZSA-N 4-[(e)-(4-fluorophenyl)methylideneamino]-3-methyl-1h-1,2,4-triazole-5-thione Chemical compound CC1=NNC(=S)N1\N=C\C1=CC=C(F)C=C1 MZWDAEVXPZRJTQ-WUXMJOGZSA-N 0.000 claims 2
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical class C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 claims 1
- 125000001425 triazolyl group Chemical group 0.000 claims 1
- JVVRJMXHNUAPHW-UHFFFAOYSA-N 1h-pyrazol-5-amine Chemical compound NC=1C=CNN=1 JVVRJMXHNUAPHW-UHFFFAOYSA-N 0.000 abstract description 13
- 238000009833 condensation Methods 0.000 abstract description 2
- 230000005494 condensation Effects 0.000 abstract description 2
- WGMHMVLZFAJNOT-UHFFFAOYSA-N 1-ethoxyethylideneazanium;chloride Chemical compound [Cl-].CCOC(C)=[NH2+] WGMHMVLZFAJNOT-UHFFFAOYSA-N 0.000 abstract 1
- WMEWGPRHFFHUAV-UHFFFAOYSA-N 5-methyl-1h-pyrazol-4-amine Chemical compound CC1=NNC=C1N WMEWGPRHFFHUAV-UHFFFAOYSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- 238000000034 method Methods 0.000 description 31
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- 229910052757 nitrogen Inorganic materials 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 125000004433 nitrogen atom Chemical group N* 0.000 description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- 125000000623 heterocyclic group Chemical group 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 150000002463 imidates Chemical class 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 125000005843 halogen group Chemical group 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 6
- 125000004430 oxygen atom Chemical group O* 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- ACKFDYCQCBEDNU-UHFFFAOYSA-J lead(2+);tetraacetate Chemical compound [Pb+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O ACKFDYCQCBEDNU-UHFFFAOYSA-J 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- FYTLHYRDGXRYEY-UHFFFAOYSA-N 5-Methyl-3-pyrazolamine Chemical compound CC=1C=C(N)NN=1 FYTLHYRDGXRYEY-UHFFFAOYSA-N 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 4
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 125000004434 sulfur atom Chemical group 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 125000004414 alkyl thio group Chemical group 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- PXNJGLAVKOXITN-UHFFFAOYSA-N 2-(4-nitrophenyl)acetonitrile Chemical compound [O-][N+](=O)C1=CC=C(CC#N)C=C1 PXNJGLAVKOXITN-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- 125000005162 aryl oxy carbonyl amino group Chemical group 0.000 description 2
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 2
- 125000005110 aryl thio group Chemical group 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- YEDVUDDWJVRKIS-UHFFFAOYSA-N cyclopenta[b]pyrrole Chemical compound C1=C[C]2[N]C=CC2=C1 YEDVUDDWJVRKIS-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- CEIPQQODRKXDSB-UHFFFAOYSA-N ethyl 3-(6-hydroxynaphthalen-2-yl)-1H-indazole-5-carboximidate dihydrochloride Chemical compound Cl.Cl.C1=C(O)C=CC2=CC(C3=NNC4=CC=C(C=C43)C(=N)OCC)=CC=C21 CEIPQQODRKXDSB-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 125000005462 imide group Chemical group 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 2
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 125000005499 phosphonyl group Chemical group 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 2
- 125000000565 sulfonamide group Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 description 2
- 125000004149 thio group Chemical group *S* 0.000 description 2
- 150000003852 triazoles Chemical class 0.000 description 2
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- DELJOESCKJGFML-RQOWECAXSA-N (z)-3-aminobut-2-enenitrile Chemical compound C\C(N)=C\C#N DELJOESCKJGFML-RQOWECAXSA-N 0.000 description 1
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 1
- SYYDFYJFQCLTMQ-UHFFFAOYSA-N 1-[2,4-bis(2-methylbutan-2-yl)phenoxy]butan-1-amine Chemical group CCCC(N)OC1=CC=C(C(C)(C)CC)C=C1C(C)(C)CC SYYDFYJFQCLTMQ-UHFFFAOYSA-N 0.000 description 1
- FOBJABJCODOMEO-UHFFFAOYSA-N 2,2,3,3,4,4,4-heptafluorobutanamide Chemical group NC(=O)C(F)(F)C(F)(F)C(F)(F)F FOBJABJCODOMEO-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- WYYVVEWZSRVHNF-UHFFFAOYSA-N 2-ethylhexanenitrile Chemical compound CCCCC(CC)C#N WYYVVEWZSRVHNF-UHFFFAOYSA-N 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical class C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- HYZOFMZMAYTGRU-UHFFFAOYSA-N 5-tert-butyl-2-methoxybenzenesulfonamide Chemical group COC1=CC=C(C(C)(C)C)C=C1S(N)(=O)=O HYZOFMZMAYTGRU-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical group CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical group NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical group NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- JGLMVXWAHNTPRF-CMDGGOBGSA-N CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O Chemical compound CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O JGLMVXWAHNTPRF-CMDGGOBGSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 101100448410 Mus musculus Gkn1 gene Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- SYOIWFNFUFXXMV-UHFFFAOYSA-N [Br].Cl Chemical compound [Br].Cl SYOIWFNFUFXXMV-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 1
- 125000005036 alkoxyphenyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- KHBQMWCZKVMBLN-IDEBNGHGSA-N benzenesulfonamide Chemical group NS(=O)(=O)[13C]1=[13CH][13CH]=[13CH][13CH]=[13CH]1 KHBQMWCZKVMBLN-IDEBNGHGSA-N 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 125000002603 chloroethyl group Chemical group [H]C([*])([H])C([H])([H])Cl 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004802 cyanophenyl group Chemical group 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CRPAPNNHNVVYKL-UHFFFAOYSA-N hexadecane-1-sulfonamide Chemical group CCCCCCCCCCCCCCCCS(N)(=O)=O CRPAPNNHNVVYKL-UHFFFAOYSA-N 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical group CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000006626 methoxycarbonylamino group Chemical group 0.000 description 1
- QBKUJCDMZUALQV-UHFFFAOYSA-N methyl 4-(4-nitrophenyl)butanimidate;hydrochloride Chemical compound Cl.COC(=N)CCCC1=CC=C([N+]([O-])=O)C=C1 QBKUJCDMZUALQV-UHFFFAOYSA-N 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- FGTVYMTUTYLLQR-UHFFFAOYSA-N n-ethyl-1-phenylmethanesulfonamide Chemical group CCNS(=O)(=O)CC1=CC=CC=C1 FGTVYMTUTYLLQR-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical group [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 1
- 150000002829 nitrogen Chemical class 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- SYQMMCZWJAEWEK-UHFFFAOYSA-N octadecane-1-sulfonamide Chemical group CCCCCCCCCCCCCCCCCCS(N)(=O)=O SYQMMCZWJAEWEK-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- QWOKKHXWFDAJCZ-UHFFFAOYSA-N octane-1-sulfonamide Chemical group CCCCCCCCS(N)(=O)=O QWOKKHXWFDAJCZ-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical compound O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- JAUCIKCNYHCSIR-UHFFFAOYSA-M sodium;2-cyanoacetate Chemical compound [Na+].[O-]C(=O)CC#N JAUCIKCNYHCSIR-UHFFFAOYSA-M 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- FWMUJAIKEJWSSY-UHFFFAOYSA-N sulfur dichloride Chemical compound ClSCl FWMUJAIKEJWSSY-UHFFFAOYSA-N 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000003419 tautomerization reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ARZGWBJFLJBOTR-UHFFFAOYSA-N tetradecanamide Chemical group CCCCCCCCCCCCCC(N)=O.CCCCCCCCCCCCCC(N)=O ARZGWBJFLJBOTR-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000005031 thiocyano group Chemical group S(C#N)* 0.000 description 1
- XJVIPPHGDPEDJL-UHFFFAOYSA-N thiourea;hydrochloride Chemical compound Cl.NC(N)=S XJVIPPHGDPEDJL-UHFFFAOYSA-N 0.000 description 1
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Landscapes
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
【発明の詳細な説明】
(発明の分野)
本発明は、新規なピラゾロ[1,5−bl[1,2,4
])リアゾール誘導体の製造方法に関する。DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to novel pyrazolo[1,5-bl[1,2,4
]) Concerning a method for producing a lyazole derivative.
(発明の背景)
橋頭位に窒素原子を有し、この窒素原子とさらにもう1
つの窒素原子の孤立電子対を含めて10個のπ電子の相
互作用が可能な、全体で最低2個、最高6個の窒素原子
を有する一般式・・・;移りうる3つの二重結合を示す
。(Background of the invention) It has a nitrogen atom at the bridgehead position, and this nitrogen atom and another
A general formula with a total of at least 2 and a maximum of 6 nitrogen atoms, in which 10 π electrons can interact, including the lone pair of electrons on each nitrogen atom...; show.
・;窒素又は炭素原子を示す。・; Indicates nitrogen or carbon atom.
で表わされる5−5縮合多環系化合物は通例「アザペン
タレン」と呼ばれる。この化合物はこれまで構造化学的
な興味、生理活性物質としての興味及び写真化学におけ
るマゼンタカプラーとしての興味から主に研究がなされ
てきた(J、 Elgureo。The 5-5 fused polycyclic compound represented by is commonly called "azapentalene". Until now, this compound has been studied mainly from the viewpoint of structural chemistry, interest as a physiologically active substance, and interest as a magenta coupler in photochemistry (J, Elgureo).
R,Jacquier、 S、 Migr+onac−
Mondon、 J、 Hetero−cyclic、
Chem、 、10 、 411 (1973)、
H,Koga。R, Jacquier, S, Migr+onac-
Mondon, J., Hetero-cyclic.
Chem, 10, 411 (1973),
H, Koga.
に、旧robe、 T、 Okamata、 Cher
t、 Pharm、 Bull−。, old robe, T, Okamata, Cher
t, Pharm, Bull-.
22、482 (1974)、 J、 Ba1ley、
J、 C,S、 Perkin 12047(837
?) 、特公昭47−27411号、特開昭50−12
11586号など参照)。22, 482 (1974), J. Balley,
J, C, S, Perkin 12047 (837
? ), Japanese Patent Publication No. 47-27411, Japanese Patent Publication No. 1977-12
11586, etc.).
しかしながら、従来の7ザペンタレン化合物は、写真用
マゼンタカプラーとして、色相及び光・熱堅牢性などの
点でまだ満足すべきものとはいえなかった。However, the conventional 7zapentalene compounds have not yet been satisfactory as photographic magenta couplers in terms of hue and light/thermal fastness.
本発明者らは、上記の従来のアザペンタレン化合物の欠
点を克服した新規なカプラー化合物を開発するため鋭意
研究を重ねた結果、ピラゾールの示す)を導入すると、
該基がピラゾール環との間で酸化閉環反応を起し、新規
なアザペンタレン化合物であるピラゾロ[1,5−bl
[1,2゜4] トリアゾール化合物が調製され、該
化合物が写真用マゼンタカプラーとして極めて優れた特
性を示すことを見い出した。本発明はこの知見に基づき
なされたものである。The present inventors have conducted intensive research to develop a new coupler compound that overcomes the drawbacks of the conventional azapentalene compounds, and as a result, when introducing pyrazole),
This group causes an oxidative ring-closing reaction with the pyrazole ring, forming a new azapentalene compound, pyrazolo[1,5-bl
[1,2°4] A triazole compound was prepared and it was found that the compound exhibits extremely excellent properties as a photographic magenta coupler. The present invention has been made based on this knowledge.
(発明の構成)
すなわち本発明は、一般式
(式中、R1及びR2は水素原子又は置換もしくは非置
換の、アルキル又はアリール基を示す。)
で表わされる化合物を酸化縮合反応させ、一般式
(式中、R1及びR2は前記と同じ意味をもつ。)
で表わされる化合物を得ることを特徴とするピラゾロ[
1,5−bl [1,2,4] トリアゾール誘導体の
製造方法を提供するものである。(Structure of the Invention) That is, the present invention subjects a compound represented by the general formula (wherein R1 and R2 represent a hydrogen atom or a substituted or unsubstituted alkyl or aryl group) to an oxidative condensation reaction to obtain a compound represented by the general formula ( In the formula, R1 and R2 have the same meanings as above.) Pyrazolo[
A method for producing a 1,5-bl [1,2,4] triazole derivative is provided.
この方法において上記一般式(II )で表わされる化
合物は、好ましくは一般式
(式中、R2は前記と同じ意味をもつ。)で表わされる
アミノピラゾールと、一般式(式中、R1は前記と同じ
意味をもち、R3はアルキル基を示す。)
で表わされ4イミドエステルと、を反応させて調製され
る。なおこの反応において副反応により一般式
(式中、R、R及びR3は前記と同じ意味を2
もつ6)
で表わされる化合物が生成するが、該化合物に塩化アン
モニウムを反応させることにより、前記一般式(II
)で表わされる化合物に転換することができる。In this method, the compound represented by the above general formula (II) is preferably an aminopyrazole represented by the general formula (wherein R2 has the same meaning as above) and a general formula (wherein R1 has the same meaning as above). (having the same meaning, R3 represents an alkyl group) is prepared by reacting with 4 imide ester. In this reaction, a compound represented by the general formula (wherein R, R and R3 have the same meanings as above) is produced by a side reaction, but by reacting this compound with ammonium chloride, the above general formula Formula (II
) can be converted to a compound represented by
また、上記方法によって得られる一般式(m)で表わさ
れる化合物にカップリング離脱基を導入すれば、一般式
(式中、R及びR2は前記と同じ意味をもち、Xはカッ
プリング離脱基を示す。)
で表わされる化合物が得られる。In addition, if a coupling-off group is introduced into the compound represented by the general formula (m) obtained by the above method, the general formula (wherein R and R2 have the same meanings as above, and ) is obtained.
本発明において、前記一般式(II )、(m)、(I
V)、(V)、(Vl)及び(■)で表わされる化合物
中、R、R及びR3のアルキル基は、2
メチル、エチル、プロピル、ブチル基のような低級アル
キル基から炭素原子数22までの高級アルキル基、例え
ば、ペンチル基、ヘキシル基、ヘプチル基、オクチル基
、デシル基、ウンデシル基、トリデシル基、オクタデシ
ル基などを意味し、直鎖でも分岐鎖でもよい。In the present invention, the general formula (II), (m), (I
In the compounds represented by V), (V), (Vl) and (■), the alkyl groups of R, R and R3 range from lower alkyl groups such as 2 methyl, ethyl, propyl and butyl groups to 22 carbon atoms. It means a higher alkyl group up to, for example, a pentyl group, hexyl group, heptyl group, octyl group, decyl group, undecyl group, tridecyl group, octadecyl group, etc., and may be linear or branched.
またR1、R2のアリール基としてはフェニル基、ナフ
チル基などがあげられ、置換アルキル基としては、2−
クロルエチル基、トリフルオロメチル基などのハロゲン
置換アルキル基、2−エトキシトリデシル基などのアル
コキシ置換アルキル基、2−アセトアミドエチル基など
アシルアミド置換アルキル基、2−メタンスルホンアミ
ドエチル基などスルホンアミド置換アルキル基、3−(
2,4−ジ−t−アミルフェノキシ)プロピル基、3−
(4−(2−[4−(4−ヒドロキシフェニルスルホ
ニル)フェノキシ] ドデカンアミド)フェニル)プロ
ピル基、ベンジル基、フェネチル基など置換もしくは無
置換のアリール基で置換されたアルキル基が、置換アリ
ール基としてはハロゲノフェニル基、ニトロフェニル基
、シアノフェニル基、アルコキシフェニル基などがあげ
られる。またこれらのR及びR2は反応に不活性な基、
例えばアルコキシル基、ニトロ基、ハロゲン原子などを
置換基として有していてもよい。Aryl groups for R1 and R2 include phenyl and naphthyl groups, and substituted alkyl groups include 2-
Halogen-substituted alkyl groups such as chloroethyl group and trifluoromethyl group, alkoxy-substituted alkyl groups such as 2-ethoxytridecyl group, acylamido-substituted alkyl groups such as 2-acetamidoethyl group, sulfonamide-substituted alkyl groups such as 2-methanesulfonamidoethyl group Group, 3-(
2,4-di-t-amylphenoxy)propyl group, 3-
An alkyl group substituted with a substituted or unsubstituted aryl group such as (4-(2-[4-(4-hydroxyphenylsulfonyl)phenoxy]dodecanamido)phenyl)propyl group, benzyl group, or phenethyl group is a substituted aryl group. Examples include halogenophenyl group, nitrophenyl group, cyanophenyl group, and alkoxyphenyl group. Moreover, these R and R2 are groups inert to the reaction,
For example, it may have an alkoxyl group, a nitro group, a halogen atom, etc. as a substituent.
なお、本発明方法により得られるピラゾロ[1,5−b
] [1,2,4] トリアゾール誘導体であって、R
1又はR2が上記のようにさら番と置換基を有する化合
物は、後記反応行程式に従って直接得ることができるが
、あるいはこの行程式でまず基本骨格であるピラゾロ[
1,5−b][1,2,4])リアゾール環を形成して
から、後続反応によって所望の置換基へと誘導してもよ
い。In addition, pyrazolo[1,5-b
] [1,2,4] Triazole derivative, R
Compounds in which 1 or R2 has a number and a substituent as described above can be obtained directly according to the reaction scheme described below, or in this scheme, the basic skeleton pyrazolo [
1,5-b][1,2,4]) The lyazole ring may be formed and then guided to a desired substituent by a subsequent reaction.
本発明方法は下記の反応行程式で表わすことができる。The method of the present invention can be expressed by the following reaction scheme.
なお、この反応行程式は前記一般式(V)で表わされる
イミドエステルを塩酸塩とし0 (■) @
(II (至)
上記反応行程式に従い本発明の実施態様を説明する。な
お、中間体(II )には下記の互変異性があると考え
られるが、
(II) ωハ
(IIA)よりも(II )の構造が主であると考えら
れるので、以下、(II )と(IIA)の混合体を単
に(II )の構造で表わすことにする。This reaction scheme is based on the hydrochloride of the imidoester represented by the general formula (V). Although (II) is thought to have the following tautomerism, it is thought that the structure of (II) is more predominant than that of (II) ωc (IIA), so below we will discuss (II) and (IIA). Let us simply represent the mixture by the structure (II).
また、イミドエステルは遊離状態で使用するよりも、少
なくとも部分的に造塩したイミドエステルのプロトン酸
塩を使用することが好ましい。造塩に使うプロトン酸と
しては、鉱酸および有機の酸を広く使用することができ
る。鉱酸としては、塩酸、臭化水素酸、硫酸、硝酸、リ
ン酸などが使用でき、有機酸としてはP−)ルエンスル
ホン酸、2.”4,6−)リメチルフェニルスルホン酸
、酢酸、モノクロル酢酸などを挙げることができる。こ
のうち好ましくはイミドエステルの塩酸塩を使用するこ
とができ、以下の説明では塩酸塩を代表例として使用す
るが、これに限定されるものではない。造塩比率は数%
の触媒量でもよいが、反応収率やイミドエステルの取扱
い易さの点から等モルあるいは化学量論量であることが
好ましい。Furthermore, it is preferable to use a protonate salt of an imidoester which has been at least partially salted than to use the imidoester in a free state. A wide variety of mineral acids and organic acids can be used as protonic acids for salt formation. As the mineral acid, hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid, etc. can be used, and as the organic acid, P-)luenesulfonic acid, 2. Examples include 4,6-)limethylphenylsulfonic acid, acetic acid, monochloroacetic acid, etc. Among these, imidoester hydrochloride can be preferably used, and in the following explanation, hydrochloride will be used as a representative example. However, it is not limited to this.The salt production ratio is several percent.
Although a catalytic amount of 100% may be used, an equimolar or stoichiometric amount is preferable from the viewpoint of reaction yield and ease of handling of the imidoester.
アミノピラゾール(IV)とイミドエステル(V)の塩
酸塩との反応は好ましくは溶媒の使用下に、0〜100
℃の温度、好ましくは20〜80°Cで、反応時間1〜
10時間の範囲で行なう。The reaction of the aminopyrazole (IV) with the hydrochloride of the imidoester (V) is preferably carried out using a solvent between 0 and 100
°C temperature, preferably 20-80 °C, reaction time 1-80 °C.
This will be done over a period of 10 hours.
反応温度がO′C未満では反応が遅い。lOO′Cを越
えても大きな問題はないが収率が低下することがある。If the reaction temperature is below O'C, the reaction is slow. Even if it exceeds lOO'C, there is no major problem, but the yield may decrease.
反応溶媒としては、イミドエステル塩酸塩か1溶な溶媒
、メタノール、エタノール、イソプロパツールなどのア
ルコール系溶媒が好ましい。The reaction solvent is preferably a solvent in which imidoester hydrochloride is soluble, or an alcoholic solvent such as methanol, ethanol, or isopropanol.
アミノピラゾール(IV)とイミドエステル(V)との
モル比はl:l〜1:2の範囲が好、ましい。The molar ratio of aminopyrazole (IV) to imidoester (V) is preferably in the range of 1:1 to 1:2.
アミノピラゾール(IV)の具体例としてt±、3−ア
ミノピラゾール、5−アミ7−3−メチルピランール、
5−アミノ−3−フェニルビラソ゛−ル、5−アミノ−
3−[3’−(p−ニトロフェニル)プロピル]ピラゾ
ールなどがあげられる。Specific examples of aminopyrazole (IV) include t±, 3-aminopyrazole, 5-ami7-3-methylpyranol,
5-amino-3-phenylvirasol, 5-amino-
Examples include 3-[3'-(p-nitrophenyl)propyl]pyrazole.
なおアミノピラゾール(IV)は市販のものを利用でき
るが、必要に応じて酸/\ロゲン化物とシアン酢酸ナト
リウムのエノラートとの反応により得たオキソプロピオ
ノニトリル誘導体とヒドラジンとの反応により合成する
ことができる。また、R2かメチル基の場合はアセトこ
トリルとナトリウムから容易に合成できる3−アミノク
ロトノニトリルとヒドラジンとの反応により(IV)(
R=−CH3)を合成できる(J、 Heterocy
cl。Note that aminopyrazole (IV) can be used as a commercially available product, but if necessary, it can be synthesized by reacting an oxopropiononitrile derivative obtained by reacting an acid/\loginide with an enolate of sodium cyanacetate and hydrazine. I can do it. In addition, if R2 is a methyl group, (IV) (
R=-CH3) can be synthesized (J, Heterocy
cl.
0hem、 、11巻、423頁、 1!374年)。0hem, vol. 11, p. 423, 1!374).
なおアミノピラシール(IV)とイミドエステル(V)
の塩酸塩との反応において、低温で反応させた場合一般
式(VDのイミドエステル化合物の比率が多くなり、高
温で長時間反応させた場合(II )の比率が多くなる
。なお副生じた一般式(VI)のイミドエステル化合物
は、過剰量の塩化アンモニウムを加えて加熱還流するこ
とにより容易に、目的の、一般式(II )で表わされ
る化合物とすることができる。Furthermore, aminopyracil (IV) and imidoester (V)
In the reaction with the hydrochloride of the general formula (II), when the reaction is carried out at a low temperature, the proportion of the imide ester compound of the general formula (VD) increases, and when the reaction is carried out at a high temperature for a long time, the proportion of the imide ester compound (II) increases. The imidoester compound of formula (VI) can be easily converted into the desired compound of general formula (II) by adding an excess amount of ammonium chloride and heating under reflux.
次に、一般式(rx )の化合物の酸化縮合による一般
式(III)のピラゾロ[1,5−b] [1゜2.4
] トリアゾール化合物の合成は、反応温度60〜15
0℃で、反応時間0.1〜5時間の範囲で行なわれる。Next, pyrazolo[1,5-b] [1°2.4] of general formula (III) is obtained by oxidative condensation of the compound of general formula (rx)
] The synthesis of the triazole compound is carried out at a reaction temperature of 60 to 15
The reaction is carried out at 0°C for a reaction time of 0.1 to 5 hours.
反応温度が上記範囲の下限未満では、例えば酸化剤の四
酢酸鉛との錯体を生成するのみで、環化生成物を与えず
、上限を越えると、生成物の分解などが起こり収率を下
げる場合がある。If the reaction temperature is below the lower limit of the above range, for example, only a complex with the oxidizing agent lead tetraacetate is formed, but no cyclized product is produced, and if it exceeds the upper limit, the product decomposes, etc., reducing the yield. There are cases.
酸化剤としては、四酢酸鉛、N−ハロゲノコハク酸イミ
ド、臭素などを1〜4当量の範囲の量を用いるが好まし
くは四酢酸鉛1当量を使用する。As the oxidizing agent, lead tetraacetate, N-halogenosuccinimide, bromine, etc. are used in an amount ranging from 1 to 4 equivalents, preferably 1 equivalent of lead tetraacetate.
反応溶媒としては、酢酸、クロロホルム、トリクミロエ
タン、テトラヒドロフラン、酢酸エチルなどが用いられ
る。As the reaction solvent, acetic acid, chloroform, tricumyloethane, tetrahydrofuran, ethyl acetate, etc. are used.
上記反応行程で、得られる所望化合物は何ら単離するこ
となく引き続く反応に供してもよいが、通常適当な単離
手段により単離精製される。このような手段としては例
えば溶媒抽出法、再結晶法、ろ適法、力?ムクロマトグ
ラフィー、薄層クロマトグラフィー等を例示できる。Although the desired compound obtained in the above reaction step may be subjected to the subsequent reaction without being isolated in any way, it is usually isolated and purified by appropriate isolation means. Examples of such methods include solvent extraction, recrystallization, filtration, and force. Examples include mucochromatography and thin layer chromatography.
本発明方法において、一般式(m)で表ゎ、されるピラ
ゾロ[1,5−bl [1,2,4] )リアゾール化
合物をさらに処理して7−位に写真用カプラーとして周
知のカップリング離脱基を導入してもよい。このような
ことは、ハロゲン化銀によって酸化された芳香族−級ア
ミンの酸化生成物とのカップリング反応速度の調整及び
使用銀量の削減のため写真用カプラー製造において適宜
に行われている手法であり、それ自体公知のことである
。In the method of the present invention, the pyrazolo[1,5-bl[1,2,4]) lyazole compound represented by the general formula (m) is further treated to form a coupling known as a photographic coupler at the 7-position. A leaving group may be introduced. This is a method that is appropriately carried out in the production of photographic couplers in order to adjust the coupling reaction rate of the aromatic-class amine oxidized by silver halide with the oxidation product and to reduce the amount of silver used. This is a well-known fact.
以下にカップリング離脱基の一般的な導入法について説
明する。A general method for introducing a coupling-off group will be explained below.
(1)酸素原子を連結する方法
本発明の方法により合成した4当量母核カプラー、ピラ
ゾロ[1,5−bl)リアゾール型カプラーと、芳香族
−級アミンの酸化生成物とを反応させて色素を形成させ
、それを酸触媒の存在下で加水分解してケトン体とし、
このケトン体をPd−炭素を触媒とする水素添加、Zn
−酢酸による還元又は水素化ホウ素ナトリウムによる還
元処理して、7−ヒトロキシーピラゾロ[1,5−bl
トリアゾールを合成することができる。これを各種ハ
ライドと反応させて目的とする酸素原子を連結したカプ
ラーが合成できる。(米国特許3.928,831号、
特開昭57−70817号参照)(2)窒素原子を連結
する方法
窒素原子を連結する方法には大きく分けて3つの方法が
ある。第1の方法は、米国特許3.41J3!Il1号
に記載されているように適当なニトロソ化剤でカップリ
ング活性位をニトロン化し、それを適当な方法で還元(
例えば、Pd−炭素等を触媒とする水素添加法、塩化第
一スズ等を使用した化学還元法)し、7−アミノ−ピラ
ゾロ[1,5−bl トリアゾールとして各種ハライ、
ドと反応させ、主としてアミド化合物は合成できる。(1) Method for linking oxygen atoms The 4-equivalent mother coupler synthesized by the method of the present invention, a pyrazolo[1,5-bl) riazole coupler, is reacted with the oxidation product of an aromatic-class amine to form a dye. and hydrolyze it in the presence of an acid catalyst to form a ketone body,
This ketone body was subjected to hydrogenation using Pd-carbon as a catalyst, Zn
- 7-hydroxypyrazolo[1,5-bl] by reduction with acetic acid or sodium borohydride
Triazoles can be synthesized. By reacting this with various halides, the desired coupler connecting oxygen atoms can be synthesized. (U.S. Pat. No. 3,928,831,
(Refer to JP-A-57-70817) (2) Method of connecting nitrogen atoms There are roughly three methods for connecting nitrogen atoms. The first method is US Pat. No. 3.41J3! The active coupling site is nitrated with a suitable nitrosating agent as described in No. 111, and then reduced (
For example, hydrogenation using Pd-carbon as a catalyst, chemical reduction using stannous chloride, etc.), 7-amino-pyrazolo[1,5-bl triazole, various halides,
Amide compounds can mainly be synthesized by reacting with
第2の方法は、米薗特許3,725,087号に記載の
方法、すなわち、適当なハロゲン化剤、例えば、fn化
スルフリル、塩素ガス、臭素、N−クロロコハク酸イミ
ド、N−ブロモコハク酸イミド等によって7−位をハロ
ゲン化し、その後、特公昭5B−45135号に記載の
方法で窒素へテロ環を適当な塩基触媒、トリエチルアミ
ン、水酸化ナトリウム、ザアザビシクロ[2、2、2]
オクタン、無水炭酸カリウム等の存在下で置換させ、7
−位に窒素原子で連結したカプラーを合成することがで
きる。酸素原子で連結した化合物のうち、7−位にフェ
ノキシ基を有する化合物もこの方法で合成することがで
きる。The second method is the method described in Yonezono Patent No. 3,725,087, that is, a suitable halogenating agent, such as fn sulfuryl, chlorine gas, bromine, N-chlorosuccinimide, N-bromosuccinimide. After that, the nitrogen heterocycle was halogenated at the 7-position by the method described in Japanese Patent Publication No. 5B-45135 using a suitable base catalyst, triethylamine, sodium hydroxide, zaazabicyclo[2,2,2]
Substitution in the presence of octane, anhydrous potassium carbonate, etc.,
A coupler linked with a nitrogen atom at the - position can be synthesized. Among compounds linked by oxygen atoms, compounds having a phenoxy group at the 7-position can also be synthesized by this method.
第3の方法は、6πまたはlOπ電子系芳香族窒素へテ
ロ環を7−位に導入する場合に有効な方法で、特公昭5
7−38577号に記載されているように前記第2の方
法で合成した7−ハロゲン体に対して2倍モル以上の6
πまたはlOπ電子系芳香族窒素へテロ環を添加し50
〜150℃で無溶媒加熱するか、またはジメチルホルム
アルデヒド、スルホランまたはへキサメチルホスホトリ
アミド等非プロトン性極性溶媒中、30〜150℃で加
熱することによって7−位に窒素原子で連結した芳香族
窒素へテロ環基を導入することができる。The third method is an effective method when introducing a 6π or 1Oπ electron system aromatic nitrogen heterocycle at the 7-position, and is
As described in No. 7-38577, more than twice the molar amount of 6 to the 7-halogen compound synthesized by the second method.
Adding π or lOπ electron system aromatic nitrogen heterocycle 50
Aromatic compounds linked by a nitrogen atom at the 7-position by heating at ~150°C without solvent or in an aprotic polar solvent such as dimethylformaldehyde, sulfolane, or hexamethylphosphotriamide at 30~150°C. A nitrogen heterocyclic group can be introduced.
(3)イオウ原子を連結する方法
芳香族メルカプト又はヘテロ環メルカプト基が7−位に
置換したカプラーは米国特許3.227.554号に記
載の方法、すなわちアリールメルカプタン、ヘテロ環メ
ルカプタン及びその対応するジスルフィドをハロゲン化
炭化水素系溶媒に溶解し、塩素又は塩化スルフリルでス
ルフェニルクロリドとし非プロトン性溶媒中に溶解した
4当量ピラゾc+[l、5−bl)リアゾール系カプラ
ーに添加し合成することが出来、ゐ。アルキルメルカプ
ト基を7−位に導入する方法としては米国特許4.28
4,723号記載の方法、すなわちカプラーのカップリ
ング活性位置にメルカプト基を導入し;このメルカプト
基にハライドを作用させる方法とS−(アルキルチオ)
イソチオ尿素塩酸塩(又は臭素塩酸)によって一工程で
合成する方法とが有効である。(3) Method of connecting sulfur atoms Couplers substituted with an aromatic mercapto or heterocyclic mercapto group at the 7-position can be prepared by the method described in U.S. Pat. It can be synthesized by dissolving a disulfide in a halogenated hydrocarbon solvent, converting it to sulfenyl chloride with chlorine or sulfuryl chloride, and adding it to a 4-equivalent pyrazo c+[l,5-bl) lyazole coupler dissolved in an aprotic solvent. Done, ゐ. As a method for introducing an alkylmercapto group into the 7-position, US Patent No. 4.28
The method described in No. 4,723, that is, the method of introducing a mercapto group into the coupling active position of the coupler; the method of acting a halide on this mercapto group, and the method of S-(alkylthio)
A one-step synthesis method using isothiourea hydrochloride (or bromine hydrochloride) is effective.
また、本発明方法においては、一般式(m)で表わされ
るピラゾロ[1,5−b] [1,2゜4] トリアゾ
ール化合物の2−位及び6−位の置換基R及びR2をそ
れ自体公知の方法、例えば上記カップリング離脱基の導
入方法に準じ、適宜処理して、写真化学的に許容される
所望の基に変換してもよい。In addition, in the method of the present invention, the substituents R and R2 at the 2-position and 6-position of the pyrazolo[1,5-b][1,2゜4] triazole compound represented by the general formula (m) are themselves It may be converted into a desired photochemically acceptable group by an appropriate treatment according to a known method, for example, the above-mentioned method for introducing a coupling-off group.
こうして本発明方法を利用して誘導されるピラゾロ;[
1,5−b] [1,2,4] )リアゾール誘導体は
次の一般式で表わすことができる。Pyrazolo thus derived using the method of the present invention; [
1,5-b] [1,2,4]) The lyazole derivative can be represented by the following general formula.
へ
但し、式中、R4,R5は水素原子又は置換基を表わし
、Xは水素原子又はカップリング離脱基を表わす。好ま
しくは、R4,R5は水素原子、ハロゲン原子、脂肪族
基、アリール基、ヘテロ環基、シアノ基、アルコキシ基
、アリールオキシ基、アシルアミノ基、アニリノ基−、
ウレイド基、スルフ7モイルアミノ基、アルキルチオ基
、アリールチオ基、アルコキシカルボニルアミノ基、ス
ルホンアミド基、カルバモイル基、スルファモイル基、
スルホニル基、アルコキシカルボニル基、ヘテロ環オキ
シ基、アシルオキシ基、カルバモイルオキシ基、シリル
オキシ基、アリールオキシカルボニルアミノ基、イミド
基、ヘテロ環チオ基、スルフィニル基、ホスホニル基、
アリールオキシカルボニル基、アシル基を表わし、Yは
水素原子、ハロゲン原子、カルボキシ基又は酸素原子、
窒素原子、炭素原子で、もしくはイオウ原子を介してカ
ップリング位の炭素と結合する基でカップリング離脱す
る基を表わし、R4、R5又はYが2価の基となりビス
体を形成してもよく、
また一般式(Vj[)で表わされる部分がビニル単量体
に含まれるときは、R又はR5のいずれかは単なる結合
又は連結基をあられし、これを介して一般式(Vl)で
表わされる部分はビニル基に結合する。In the formula, R4 and R5 represent a hydrogen atom or a substituent, and X represents a hydrogen atom or a coupling-off group. Preferably, R4 and R5 are a hydrogen atom, a halogen atom, an aliphatic group, an aryl group, a heterocyclic group, a cyano group, an alkoxy group, an aryloxy group, an acylamino group, an anilino group,
ureido group, sulf7moylamino group, alkylthio group, arylthio group, alkoxycarbonylamino group, sulfonamide group, carbamoyl group, sulfamoyl group,
Sulfonyl group, alkoxycarbonyl group, heterocyclic oxy group, acyloxy group, carbamoyloxy group, silyloxy group, aryloxycarbonylamino group, imide group, heterocyclic thio group, sulfinyl group, phosphonyl group,
represents an aryloxycarbonyl group or an acyl group, Y is a hydrogen atom, a halogen atom, a carboxy group or an oxygen atom,
Represents a group that couples off with a nitrogen atom, a carbon atom, or a group that bonds to a carbon at a coupling position via a sulfur atom, and R4, R5, or Y may be a divalent group to form a bis form. , In addition, when the vinyl monomer contains a moiety represented by the general formula (Vj[), either R or R5 represents a simple bond or a linking group, and through this, the moiety represented by the general formula (Vl) is The moiety bonded to the vinyl group.
さらに詳しくは、R4,R5は各々水素原子、ハロゲン
原子(例えば、塩素原子、臭素原子、等)アルキル基(
炭素数1〜32の直鎖、分岐鎖アルキル基、アラルキル
基、アルケニル基、アルキニル基、シクロアルキル基、
シクロアルケニル基、で、これらは酸素原子、窒素原子
、イオウ原子、カルボニル基で連結する置換基、ヒドロ
キシ基、アミン基、ニトロ基、カルボキシ基、シアノ基
、又はハロゲン原子で置換していてもよく、例えば、メ
チル基、プロピル基、t−ブチル基、トリデシル基、2
−メタンスルホニルエチル基、3−(3−ペンタデシル
フェノキシ)プロピル基、3− (4−(2−[4−(
4−ヒドロキシフェニルスルホニル)フェノキシ] ド
デカンアミノ)フェニル)プロピル基、2−エトキシト
リデシル基、トリフルオロメチル基、シクロペンチル基
、3−(2,4−ジ−t−アミルフェノキシ)プロピル
基、等)アリール基(例えば、フェニル基、4−t−ブ
チルフェニル基、2,4−ジーを一アミルフェニル基、
4−テトラデカンアミドフェニル基、等)、ヘテロ環
基(例えば、2−フリル基、?−チェニル基、2−ピリ
ミジニル基、2−ベンゾチアゾリル基、等)、シアン基
、アルコキシ基(例えばメトキシ基、エトキシ基、2−
メトキシエトキシ基、2−ドデシルエトキシ基、2−メ
タンスルホニルエトキシ基、等)、アリールオキシ基(
例えば、フェノキシ基、2−メチルフェノキシ基、4−
t−ブチルフェノキシ基、等)、アシルアミノ基(例え
ば、アセトアミド基、ベンズアミド基、テトラデカンア
ミド基、α−(2,4−ジ−t−アミルフェノキシ)ブ
チルアミド基、γ−(3−t、−ブチル−4−ヒドロキ
シフェノキシ)ブチルアミド基、α−(4−(4−ヒド
ロキシフェニルスルホニル)フェノキシ・)デカンアミ
ド基、等)、アこリノ基(例えばフェニルアミノ基、2
−クロロアニリノ基、?−クロロー5−テトラデカンア
ミノアニリノ基、2−クロロ−5−ドデシルオキシカル
ボニルアニリノ&、N−アセチルアニリノ基、2−クロ
ロ−5−(α−(3−t−ブチル−4−ヒドロキシフェ
ノキシ)ドデカンアミド)アニリノ基、等)、ウレイド
基(例えば、フェニルウレイド基、メチルウレイド基、
N、N−ジブチルウレイド基、等)、スルファモイルア
ミ7基(例えば、N、N−ジプロピルスルファモイルア
ミノ基、N−メチル−N−デシルスルファモイルアミノ
基、等)、アルキルチオ基(例えば、メチルチオ基、オ
クチルチオ基、テトラデシルチオ基、2−フェノキシエ
チルチオ基、3−フェノキシプロピルチオ基、3−(4
−t−ブチルフェノキシ)プロピルチオ基、等)、アリ
ールチオ基(例えば、フェニルチオ基、2−ブトキシ−
5−t−才クチルフェニルチオ基、3−ペンタデシルフ
ェニルチオ基、2−カルボキシフェニルチオ基、4−テ
トラデカンアミドフェニルチオ基、等)、アルコキシカ
ルボニルアミン基(例えば、メトキシカルボニルアミノ
基、テトラデシルオキシカルボニルアミノ基、等)、ス
ルホンアミド基(例えば、メタンスルホンアミド基、ヘ
キサデカンスルホンアミド基、ベンゼンスルホンアミド
基、P−)ルエンスルホンアミド基、オクタデカンスル
ホンアミド基、2−メチルオキシ−5−t−ブチルベン
ゼンスルホンアミド基、等)、カルバモイル基(例えば
、N−エチルカルバモイル基、N、N−ジブチルカルバ
モイル基、N−(2−ドデシルオキシエチル)カルバモ
イル基、N−メチル−N−ドデシルカルバモイル基、N
−(3−(2,4−ジーt−7ミルフエノキシ)プロヒ
ル)カルバモイル基、等)、スルファモイル基(例えば
、N−エチルスルファモイル、1.N、N〜ジプロピル
スルファモイル基、N−(2−ドデシルオキシエチル)
スルファモイル基、N−エチル−N−ドデシルスルファ
モイル基、N、N−ジエチルスルファモイル基、等)、
スルホニル基(例えば、メタンスルホニル基、オクタン
スルホニル基、ベンゼンスルホニル基、トルエンスルホ
ニル基、等)、アルコキシカルボニル基(例えば、メト
キシカルボニル基、ブチルオキシカルボニル基、ドデシ
ルオキシカルボニル基、オクタデシルオキシカルボニル
基、等)、ペテロ環オキシ基(例えば、l−フェニルテ
トラゾール−5−オキシ基、2−テトラヒドロピラニル
オキシ基、等)、アシルオキシ基(例えば、アセトキシ
基、等)、カルバモイルオキシ基(例えば、N−メチル
カルバモイルオキシ基、N−フェニルカルバモイルオキ
シ基、等)、シリルオキシ基(例えば、トリメチルシリ
ルオキシ基、ジブチルメチルシリルオキシ基、等)、ア
リールオキシカルボニルアミノ基(例えば、フェノキシ
カルボニルアミノ基、等)、イミド基(例えば、N−ス
クシンイミド基、N−フタルイミFM、3−オクタデセ
ニルスルシンイミド基、等)、ヘテロ環チオ基(例えば
、2−ベンゾチアゾリルチオ基、2,4−ジ−フェノキ
シ−1゜3.5−トリアゾール−6−チオ基、2−ピリ
ジルチオ基、等)、スルフィニル基(例えば、ドデカン
スルフィニル基、3−ペンタデシルフェニルスルフィニ
ル基、3−フェノキシプロピルスルフィニル基、等)、
ホスホニル基(例えば、フェノキシホスホニル基、オク
チルオキシホスホニル基、フェニルホスホニル基、等)
、アリールオキシカルボニル基(例えば、フェノキシカ
ルボニル基、等)、アシル基(例えば、アセチル基、3
−フェニルプロパノイル基、ベンゾイル基、4−ドデシ
ルオキシベンゾイル基、等)を表わし、Xは水素原子、
ハロゲン原子(例えば、塩素原子、臭素原子、ヨウ素原
子等)、カルボキシ基、又は酸素原子で連結する基(例
えば、アセトキシ基、プロパノイルオキシ基、ベンゾイ
ルオキシ基、?、4−ジクロロベンゾイルオキシ基、エ
トキシオキザロイルオキシ基、ピルビニルオキシ基、シ
ンナモイルオキシ基、フェノキシ基、4−シアノフェノ
キジル基、4−メタンスルホンアミドフェノキシ基、4
−ンタンスルホニルフェノキシ基、α−ナフトキシ基、
3−ペンタデシルフ゛エノキシ基、ベンジルオキシカル
ボニルオキシ基、エトキシ基、2−シアノエトキシ基、
ベンジルオキシ基、2−フェネチルオキシ基、2−フェ
ノキシエトキシ基、5−フェニルテトラゾリルオキシ基
、2−ベンゾチアゾリルオキシ基、等)、窒素原子で連
結する基(例えば、ベンゼンスルホンアミド基、N−エ
チルトルエンスルホンアミド基、ヘプタフルオロブタン
アミド基、2,3,4゜5.6−ベンタフルオロベンズ
アミド基、オクタンスルホンアミド基、p−シアノフェ
ニルウレイド基、N、N−ジエチルスルファモノイルア
ミ7基、 l−ピペリジル基、5.5−ジメチル−2,
4−ジオキソ−3−オキサゾリジニル基、l−ベンジル
−エトキシ−3−ヒタントイニル基、2N−1,1−ジ
オキソ−3(2)1)−オキソ−1,2−ベンゾインチ
アゾリル基、2−オキソ−1,2−ジヒドロ−1−ピリ
ジニル基、イミダゾリル基、ピラゾリル基、3.5−ジ
エチル−1゜2.4−トリアゾール−1−イル、5又は
6−プロモベンゾトリアゾールー1−イル、5−メチル
−1,2,3,4−)リアゾール−1−イル基、ベンズ
イミダゾリル基、4−メトキシフェニルアゾ基、4−ピ
バロイルアミノフェニルアゾ基。2−ヒドロキシ−4−
プロパノイルフェニルアゾ基、等)、イオウ原子で連結
する基(例えば、フェニルチオ基、2−カルボキシフェ
ニルチオ基、2−メトキシ−5−を−オクチルフェニル
チオ基、4−メタンスルホニルフェニルチオ基、4−オ
クタンスルホンアミドフェニルチオ基、ベンジルチオ基
、2−シアノエチルチオ基、l−エトキシカルボニルト
リデシルチオ基、5−フェニル−2,3,4,5−テト
ラゾリルチオ基、2−ベンゾチアゾリル基、チオシアノ
基、N、N−ジエチルチオカルボニルチオ基、ドデシル
オキシチオカルボニルチオ基、等)、炭素原子で連結す
る基(例えば、トリフェニルメチル基、ヒドロキシメチ
ル基、N−モルホリノメチル基、
八
但しR,、R5は水素原子、アルキル基、アリール基、
ヘテロ環基を表わし、R4,R5はすでに定義したと同
じ意味を有する、等)、を表わす。More specifically, R4 and R5 are each a hydrogen atom, a halogen atom (for example, a chlorine atom, a bromine atom, etc.), an alkyl group (
Straight chain or branched alkyl groups, aralkyl groups, alkenyl groups, alkynyl groups, cycloalkyl groups having 1 to 32 carbon atoms,
A cycloalkenyl group, which may be substituted with an oxygen atom, nitrogen atom, sulfur atom, a substituent linked with a carbonyl group, a hydroxy group, an amine group, a nitro group, a carboxy group, a cyano group, or a halogen atom. , for example, methyl group, propyl group, t-butyl group, tridecyl group, 2
-methanesulfonylethyl group, 3-(3-pentadecylphenoxy)propyl group, 3-(4-(2-[4-(
4-hydroxyphenylsulfonyl)phenoxy] dodecamino)phenyl)propyl group, 2-ethoxytridecyl group, trifluoromethyl group, cyclopentyl group, 3-(2,4-di-t-amylphenoxy)propyl group, etc.) Aryl group (e.g., phenyl group, 4-t-butylphenyl group, 2,4-di-monoamyl phenyl group,
4-tetradecanamidophenyl group, etc.), heterocyclic group (e.g., 2-furyl group, ?-chenyl group, 2-pyrimidinyl group, 2-benzothiazolyl group, etc.), cyan group, alkoxy group (e.g., methoxy group, ethoxy group, 2-
methoxyethoxy group, 2-dodecylethoxy group, 2-methanesulfonylethoxy group, etc.), aryloxy group (
For example, phenoxy group, 2-methylphenoxy group, 4-
t-butylphenoxy group, etc.), acylamino group (e.g., acetamide group, benzamide group, tetradecanamide group, α-(2,4-di-t-amylphenoxy)butylamide group, γ-(3-t,-butyl) -4-hydroxyphenoxy)butyramide group, α-(4-(4-hydroxyphenylsulfonyl)phenoxy·)decaneamide group, etc.), achorino group (e.g. phenylamino group, 2
-Chloroanilino group, ? -chloro-5-tetradecanaminoanilino group, 2-chloro-5-dodecyloxycarbonylanilino & N-acetylanilino group, 2-chloro-5-(α-(3-t-butyl-4-hydroxyphenoxy) ) dodecanamide) anilino group, etc.), ureido group (e.g. phenylureido group, methylureido group,
N,N-dibutylureido group, etc.), sulfamoylamide 7 group (e.g., N,N-dipropylsulfamoylamino group, N-methyl-N-decylsulfamoylamino group, etc.), alkylthio group ( For example, methylthio group, octylthio group, tetradecylthio group, 2-phenoxyethylthio group, 3-phenoxypropylthio group, 3-(4
-t-butylphenoxy)propylthio group, etc.), arylthio group (e.g., phenylthio group, 2-butoxy-
5-t-cutylphenylthio group, 3-pentadecylphenylthio group, 2-carboxyphenylthio group, 4-tetradecanamidophenylthio group, etc.), alkoxycarbonylamine group (e.g., methoxycarbonylamino group, tetradecyl oxycarbonylamino group, etc.), sulfonamide group (e.g. methanesulfonamide group, hexadecanesulfonamide group, benzenesulfonamide group, P-)luenesulfonamide group, octadecanesulfonamide group, 2-methyloxy-5-t -butylbenzenesulfonamide group, etc.), carbamoyl group (e.g., N-ethylcarbamoyl group, N,N-dibutylcarbamoyl group, N-(2-dodecyloxyethyl)carbamoyl group, N-methyl-N-dodecylcarbamoyl group) , N
-(3-(2,4-di-t-7-milphenoxy)proyl)carbamoyl group, etc.), sulfamoyl group (e.g., N-ethylsulfamoyl, 1.N,N~dipropylsulfamoyl group, N-( 2-dodecyloxyethyl)
sulfamoyl group, N-ethyl-N-dodecylsulfamoyl group, N,N-diethylsulfamoyl group, etc.),
Sulfonyl groups (e.g. methanesulfonyl group, octanesulfonyl group, benzenesulfonyl group, toluenesulfonyl group, etc.), alkoxycarbonyl groups (e.g. methoxycarbonyl group, butyloxycarbonyl group, dodecyloxycarbonyl group, octadecyloxycarbonyl group, etc.) ), peterocyclic oxy groups (e.g. l-phenyltetrazol-5-oxy group, 2-tetrahydropyranyloxy group, etc.), acyloxy groups (e.g. acetoxy group, etc.), carbamoyloxy groups (e.g. N-methyl carbamoyloxy group, N-phenylcarbamoyloxy group, etc.), silyloxy group (e.g., trimethylsilyloxy group, dibutylmethylsilyloxy group, etc.), aryloxycarbonylamino group (e.g., phenoxycarbonylamino group, etc.), imide group (e.g., N-succinimide group, N-phthalimide FM, 3-octadecenylsulcinimide group, etc.), heterocyclic thio group (e.g., 2-benzothiazolylthio group, 2,4-di-phenoxy-1 3.5-triazole-6-thio group, 2-pyridylthio group, etc.), sulfinyl group (e.g., dodecanesulfinyl group, 3-pentadecylphenylsulfinyl group, 3-phenoxypropylsulfinyl group, etc.),
Phosphonyl group (e.g., phenoxyphosphonyl group, octyloxyphosphonyl group, phenylphosphonyl group, etc.)
, aryloxycarbonyl group (e.g., phenoxycarbonyl group, etc.), acyl group (e.g., acetyl group, 3
- phenylpropanoyl group, benzoyl group, 4-dodecyloxybenzoyl group, etc.), where X is a hydrogen atom,
A halogen atom (e.g., chlorine atom, bromine atom, iodine atom, etc.), a carboxy group, or a group linked with an oxygen atom (e.g., acetoxy group, propanoyloxy group, benzoyloxy group, ?, 4-dichlorobenzoyloxy group, Ethoxyoxaloyloxy group, pyruvinyloxy group, cinnamoyloxy group, phenoxy group, 4-cyanophenokyl group, 4-methanesulfonamidophenoxy group, 4
-thanesulfonylphenoxy group, α-naphthoxy group,
3-pentadecylphenoxy group, benzyloxycarbonyloxy group, ethoxy group, 2-cyanoethoxy group,
benzyloxy group, 2-phenethyloxy group, 2-phenoxyethoxy group, 5-phenyltetrazolyloxy group, 2-benzothiazolyloxy group, etc.), groups linked through nitrogen atoms (e.g., benzenesulfonamide group) , N-ethyltoluenesulfonamide group, heptafluorobutanamide group, 2,3,4゜5.6-bentafluorobenzamide group, octanesulfonamide group, p-cyanophenylureido group, N,N-diethylsulfamono ylami 7 group, l-piperidyl group, 5,5-dimethyl-2,
4-dioxo-3-oxazolidinyl group, l-benzyl-ethoxy-3-hytantoynyl group, 2N-1,1-dioxo-3(2)1)-oxo-1,2-benzointhiazolyl group, 2-oxo -1,2-dihydro-1-pyridinyl group, imidazolyl group, pyrazolyl group, 3.5-diethyl-1゜2.4-triazol-1-yl, 5- or 6-promobenzotriazol-1-yl, 5- Methyl-1,2,3,4-)lyazol-1-yl group, benzimidazolyl group, 4-methoxyphenylazo group, 4-pivaloylaminophenylazo group. 2-hydroxy-4-
(propanoylphenylazo group, etc.), groups linked by a sulfur atom (e.g., phenylthio group, 2-carboxyphenylthio group, 2-methoxy-5-octylphenylthio group, 4-methanesulfonylphenylthio group, -Octanesulfonamidophenylthio group, benzylthio group, 2-cyanoethylthio group, l-ethoxycarbonyltridecylthio group, 5-phenyl-2,3,4,5-tetrazolylthio group, 2-benzothiazolyl group, thiocyano group, N , N-diethylthiocarbonylthio group, dodecyloxythiocarbonylthio group, etc.), groups linked by carbon atoms (e.g., triphenylmethyl group, hydroxymethyl group, N-morpholinomethyl group, hydrogen atom, alkyl group, aryl group,
represents a heterocyclic group, R4 and R5 have the same meanings as defined above, etc.).
R,、R5又はXが2価の基となってビス体を形成する
2価の基をさらに詳しく述べれば、R4,R5は置換又
は無置換のアルキレン基、例えば、メチレン基、エチレ
ン基、1.10−デシレン基、−CH2CH2−O−C
H2CH2−1等)、置換又は無置換のフェニレン基(
例えば、1.4−フェニレン基、l、3−フェニレン基
、
−NHCO−R8−CONH−基(R8は置換もしくは
無置換のフルキレン基又はフェニレン基を−NHCOC
H2CH2CONH−1
H3
を示す、)である。To describe in more detail the divalent group in which R, R5 or .10-decylene group, -CH2CH2-O-C
H2CH2-1, etc.), substituted or unsubstituted phenylene groups (
For example, 1,4-phenylene group, l,3-phenylene group, -NHCO-R8-CONH- group (R8 is substituted or unsubstituted fullkylene group or phenylene group -NHCO-R8-CONH- group)
), representing H2CH2CONH-1 H3.
次に、上記一般式(9N)で表わされるピラゾロ[1,
5−b] [1,2,41トリアゾール誘導体の具体例
を以下に例示するが、本発明はこれによって限定される
ものでないことは勿論である。Next, pyrazolo[1,
5-b] [Specific examples of the 1,2,41 triazole derivatives are illustrated below, but it goes without saying that the present invention is not limited thereto.
特開昭GO−215687(11)
瓢
C轡
(flS
n −C1−嘔
上記の例示化合物の物理的データの代表として融点を次
表にまとめた。JP-A-215687 (11) Melting points are summarized in the following table as representative physical data of the above-mentioned exemplified compounds.
)
)
ノ/
(発明の効果)
本発明によれば、カラー写真のマゼンタカプラーとして
、カラー拡散転写法写真の色素現像薬、色素放出剤合成
中曲体としてまた、写真用増感色素製造の中間体として
有用な、新規なアザペンタレン化合物であるピラゾロ[
1,5−b][1,2,41トリアゾール誘導体を製造
することができる。また本発明の化合物は、生理活性物
質として使用できる可能性を有し、さらに医薬品製造の
中間体となりうる。)) ノ/ (Effects of the Invention) According to the present invention, it can be used as a magenta coupler in color photography, as a dye developer in color diffusion transfer photography, as a compound during the synthesis of a dye release agent, and as an intermediate in the production of sensitizing dyes for photography. Pyrazolo [
1,5-b][1,2,41 triazole derivatives can be produced. Furthermore, the compound of the present invention has the possibility of being used as a physiologically active substance, and can also be used as an intermediate for pharmaceutical production.
この化合物は、芳香族−級アミンの酸化生成物とカップ
リングして、極めて色相良好でかつ従来のピラゾロン系
の色素より、光、熱堅牢性が優れたマゼンタ色素を生成
する。This compound is coupled with an oxidation product of an aromatic-grade amine to produce a magenta dye with extremely good hue and superior light and heat fastness than conventional pyrazolone dyes.
(実施例)
次に本発明を実施例に基づきさらに詳細に説明〈実施例
1〉
(転) (■)1
3−アミノクロトノニトリルとヒドラジン水和物の反応
によって得られたーアミノー3−メチルピラゾール(I
V) 10g (0,103mol )と7セトイミド
酸エチル塩酸塩12.7g(0,103mol)をエタ
ノール200mMに溶かし、室温で約30分間攪拌後約
3時間加熱還流した。(この場合1)の副生はほとんど
なかった。)溶液を2N水酸化ナトリウム水溶液で中和
後、藷を減圧留去し、残渣にエタノールとクロロホルム
の1=1混合溶媒を加え、不溶物の塩をろ過により除去
した。ろ液を濃縮し、油状物(部分的に結晶化)として
得られた(II)を酢酸50mJLに溶かし、室温で四
酢酸鉛49.8g(0,103mol)を少しづつ、窒
素気流下加えた。加え終わったのち2時間加熱還流した
。(Example) Next, the present invention will be explained in more detail based on Examples. Example 1 (Transformation) (■) 1 -Amino-3-methyl obtained by reaction of 3-aminocrotononitrile and hydrazine hydrate Pyrazole (I
V) 10 g (0,103 mol) and 12.7 g (0,103 mol) of ethyl 7cetimidate hydrochloride were dissolved in 200 mM ethanol, stirred at room temperature for about 30 minutes, and then heated under reflux for about 3 hours. (In this case, there was almost no by-product of 1). ) After neutralizing the solution with a 2N aqueous sodium hydroxide solution, the phlegm was distilled off under reduced pressure, a 1=1 mixed solvent of ethanol and chloroform was added to the residue, and insoluble salts were removed by filtration. The filtrate was concentrated, and (II) obtained as an oil (partially crystallized) was dissolved in 50 mJL of acetic acid, and 49.8 g (0,103 mol) of lead tetraacetate was added little by little at room temperature under a nitrogen stream. . After the addition was completed, the mixture was heated under reflux for 2 hours.
酢酸を減圧留去し、クロロホルムとメタノールの5:l
混合溶媒を加え、不溶物を除き、その後シリカゲルカラ
ムクロマトグラフィーで精製することより、1を1.4
g得た。Distill the acetic acid under reduced pressure and add 5:1 of chloroform and methanol.
By adding a mixed solvent, removing insoluble materials, and then purifying with silica gel column chromatography, 1 was converted to 1.4
I got g.
融点274〜275℃(分解)
質量分析 136(M”、100%)
元素分析値 C(%) H(%) N(%)理論値 5
2.93 5.112 41.15測定値 52.88
B、03 41.0?核磁気共鳴スペクトル
(CDC見 :ビリジンーd5=1:1)δ(p p
m) : 2.35(3H,s) 2.42(3)1.
s)5.50(IH,s)
〈実施例2〉
(IQ 1フ
ィソカプ−ロイミド酸メチル塩酸塩は市販のイソカブミ
ニトリルから通常の方法により定量的に合成することが
できた。Melting point 274-275℃ (decomposition) Mass spectrometry 136 (M”, 100%) Elemental analysis value C (%) H (%) N (%) Theoretical value 5
2.93 5.112 41.15 Measured value 52.88
B, 03 41.0? Nuclear magnetic resonance spectrum (CDC observation: viridine-d5=1:1) δ(p p
m): 2.35 (3H, s) 2.42 (3) 1.
s) 5.50 (IH, s) <Example 2> (IQ 1 Methyl physocaproimidate hydrochloride could be quantitatively synthesized from commercially available isocabminitril by a conventional method.
5−アミノ−3−メチルピラゾール20g(0、206
+*ol )とインカプロイミド酸メチル塩酸塩51g
(0,309園o1 )をメタノール200mJLに溶
かし、室温で約1時間攪拌すると主生成物(II )と
副生成物(Vl)のスポットがシリカゲルTLC(クロ
ロホルム:メタノール=6=1)で観測された。この溶
液中に塩化アンモニウム5gを加え、約2時間加熱還流
すると(Vl)は消失し、はとんど(II )となった
。ろ通抜メタノールを減圧留去し、残渣にクロロホルム
とメタノールの5=1混合溶媒を加え、不溶物をろ過し
て除いた。こうして得られた粗生成物を〈実施例1)と
示した方法により酸化して、3.2gの17を得ること
ができた。20 g of 5-amino-3-methylpyrazole (0,206
+*ol) and methyl incaproimidate hydrochloride 51g
(0,309 o1) was dissolved in 200 mJL of methanol and stirred at room temperature for about 1 hour. Spots of the main product (II) and by-product (Vl) were observed on silica gel TLC (chloroform:methanol = 6 = 1). Ta. When 5 g of ammonium chloride was added to this solution and heated under reflux for about 2 hours, (Vl) disappeared and became mostly (II). The filtered methanol was distilled off under reduced pressure, a 5=1 mixed solvent of chloroform and methanol was added to the residue, and insoluble matter was removed by filtration. The crude product thus obtained was oxidized by the method described in Example 1 to yield 3.2 g of 17.
融点140〜142℃
質量分析 192 (M”)136 (b、p)核磁気
共鳴スペクトル(CDC見。)
δ (p p m) : Q、90(OH,d、J=7
)1.55〜1.110(3N) 2.45(3H,s
) 2.90(2H,brt。Melting point 140-142°C Mass spectrometry 192 (M”) 136 (b, p) Nuclear magnetic resonance spectrum (observed by CDC) δ (p p m): Q, 90 (OH, d, J=7
) 1.55 to 1.110 (3N) 2.45 (3H, s
) 2.90 (2H, brt.
J=7) 5.80(IH,s) 13.3(IH)(
実施例3)
8
2−エチルへ午すン酸クロリドから2−エチルヘキサン
ニトリルはOrg、 Syn、 Ca11. Vol、
3巻490頁(1955年)に記載の方法によって合成
し、それをメタノール1当量に溶かし、その溶液に0℃
で、乾燥塩化水素ガスを1当量吸収させた。そして冷蔵
庫中(〜5℃)で約20日間放置するとメチルイミドエ
ステル塩酸塩の結晶が析出するのでエーテルを加えろ別
した。収率48%このイミドエステル塩酸塩Log(5
1,6m+wol)と(IV)(R2=−CH3)5
g (51、5m+5ol)とをメタノール150mJ
L中40℃で攪拌した。約7時間後T L C(S I
O2、クロロホルム:エタノール=4:l)をみると
2つのスポットが観測された。極性の低いスボ−/ )
は(Vl)の構造をもつ。この溶液に過剰量の塩化アン
モニウムを加え、約2時間加熱還流すると(Vl)は消
失しく II )のみとなる。メタノールを減圧留去し
、残渣にクロロ永ルム50 m lとメタノール10m
Mを加え不溶物をろ過して除いた。ろ液を濃縮後、少量
のシリカゲルカラムにより精製すると(II )が油状
物として8g(70%)得られた。J=7) 5.80 (IH, s) 13.3 (IH) (
Example 3) 2-Ethylhexanenitrile from 8-2-ethyl acetic acid chloride was prepared by Org, Syn, Ca11. Vol.
It was synthesized by the method described in Vol. 3, p. 490 (1955), dissolved in 1 equivalent of methanol, and added to the solution at 0°C.
1 equivalent of dry hydrogen chloride gas was absorbed. When the mixture was left in a refrigerator (~5°C) for about 20 days, crystals of methylimide ester hydrochloride precipitated, so ether was added thereto and filtered. Yield 48% of this imidoester hydrochloride Log(5
1,6m+wol) and (IV) (R2=-CH3)5
g (51,5m+5ol) and methanol 150mJ
The mixture was stirred at 40° C. in L. Approximately 7 hours later TLC (S I
When looking at O2, chloroform:ethanol=4:l), two spots were observed. Low polarity Subo/ )
has the structure (Vl). When an excess amount of ammonium chloride is added to this solution and heated under reflux for about 2 hours, (Vl) disappears and only II) is left. Methanol was distilled off under reduced pressure, and the residue was mixed with 50 ml of chloroform and 10 ml of methanol.
M was added and insoluble matter was removed by filtration. After concentrating the filtrate, it was purified using a small amount of silica gel column to obtain 8 g (70%) of (II) as an oil.
核磁気共鳴スペクトル
(CI)C1:CD30D=3:2)
δ (P P m) : 0.7〜1.2(8H) 1
.2〜L、5(4H)1.8 〜2.1(4H) 2.
32(3)1.s) 2.80(18,quintet
。Nuclear magnetic resonance spectrum (CI) C1:CD30D=3:2) δ (P P m): 0.7-1.2 (8H) 1
.. 2-L, 5 (4H) 1.8-2.1 (4H) 2.
32(3)1. s) 2.80 (18, quintet
.
J=7) 5.70(38,broad) 8.20(
IH,5)(II) 2 、6 g (12mmol)
を50m見の酢酸に溶かし、室温で四酢酸鉛5.8g
(12mmol)を少しずつ、窒素気流下加えた。加え
終わったのち、3時間加熱還流した。酢酸を減圧留去し
、クロロホルムとエタノールの30=1混合溶媒で3回
抽出し、飽和重炭酸ナトリウム水溶液と食塩水で洗浄後
硫酸マグネシウムで乾燥した。ろ過、そして濃縮後シリ
カゲルクロマトグラフィーで精製することにより18を
0.15g(5,7%)得た。融点llO〜115℃
質量分析 220 (M”)、15’5,130核磁気
共鳴スペクトル(CDCl2)
δ(p p m) : 0.7〜1.2(OH) 1.
2〜1.55(4H)1.55〜2.20(4H) 2
.45(3H,s) 2.95(IH,qujntet
。J=7) 5.70 (38, broad) 8.20 (
IH, 5) (II) 2, 6 g (12 mmol)
Dissolve in 50m of acetic acid and add 5.8g of lead tetraacetate at room temperature.
(12 mmol) was added little by little under a nitrogen stream. After the addition was completed, the mixture was heated under reflux for 3 hours. Acetic acid was distilled off under reduced pressure, extracted three times with a 30=1 mixed solvent of chloroform and ethanol, washed with a saturated aqueous sodium bicarbonate solution and brine, and dried over magnesium sulfate. After filtration and concentration, the product was purified by silica gel chromatography to obtain 0.15 g (5.7%) of 18. Melting point 110~115°C Mass spectrometry 220 (M”), 15'5,130 Nuclear magnetic resonance spectrum (CDCl2) δ (pp m): 0.7~1.2 (OH) 1.
2-1.55 (4H) 1.55-2.20 (4H) 2
.. 45 (3H, s) 2.95 (IH, qujntet
.
J−7) 5.62(1)1. s) 12.8(IH
)〈実施例4〉
4−(p−ニトロフェニル)ブチロイミド酸メチル塩酸
塩はまず4−(p−ニトロフェニル)醋酸からニトリル
を合成し、それをメタノール(1当量)中、乾燥塩化水
素ガス、1当量以上で処理して97%の収率で合成した
。J-7) 5.62(1)1. s) 12.8 (IH
) <Example 4> Methyl 4-(p-nitrophenyl)butyroimidate hydrochloride was prepared by first synthesizing nitrile from 4-(p-nitrophenyl)acetic acid, and then adding it to methanol (1 equivalent) with dry hydrogen chloride gas, It was synthesized with a yield of 97% by treating with 1 equivalent or more.
5−アミノ−3−メチルピラゾールlog(0,103
mo1)と26.6g(0,103mol)(7)4
(P−ニトロフェニル)ブチロイミド酸メチル塩酸塩か
ら、〈実施例1> <実施例2)とほぼ同様の操作で1
9を3.5g得ることができた。融点203〜212℃
質量分析 285(M”″)149 (b、p)核磁気
共鳴スペクトル(DMSO−’d8)δ (p p m
) : 2.05(2H,m) 2.45(3H,s)
2.58〜2.88(4H,m) 5.80(IH,s
) 7.25(2H,d。5-amino-3-methylpyrazole log (0,103
mo1) and 26.6g (0,103mol) (7)4
From methyl (P-nitrophenyl)butyroimidate hydrochloride, <Example 1> In almost the same manner as <Example 2), 1
I was able to obtain 3.5g of 9. Melting point 203-212°C Mass spectrometry 285 (M"") 149 (b, p) Nuclear magnetic resonance spectrum (DMSO-'d8) δ (p p m
): 2.05 (2H, m) 2.45 (3H, s)
2.58-2.88 (4H, m) 5.80 (IH, s
) 7.25 (2H, d.
J=8.0) 8.05(2)1. d、J=8.0)
(実施例5〉
(II) 醤
p−ニトロフェニルアセトニトリルはメタノールにあま
り溶けないが、1当量のメタノールに懸濁した状態で1
当量以上の塩化水素ガスを吸収させ、−晩、冷蔵庫に放
置することにより定量的に、イミド酸メチル塩酸塩を合
成できた。J=8.0) 8.05(2)1. d, J=8.0)
(Example 5) (II) Sauce p-nitrophenylacetonitrile is not very soluble in methanol, but when suspended in 1 equivalent of methanol, 1
Methyl imidate hydrochloride could be quantitatively synthesized by absorbing more than an equivalent amount of hydrogen chloride gas and leaving it in the refrigerator overnight.
このイミド酸メチル塩酸塩23g(0,1■ol)と5
−アミノ−3−メチルピラゾール9.7g(0、1mo
l )とから(実施例1> (実施例2〉とほぼ同様の
操作で32を2.8g得ることがで核磁気共鳴スペクト
ル(DMSO−d6)δ(P P m) 、: 2.0
5(2H,i) 2.45(3)1. s)2.56〜
2.88(4)1. 履) 5.60(IH,s) 7
.25(2H,d。23 g (0.1 ol) of this methyl imide hydrochloride and 5
-amino-3-methylpyrazole 9.7 g (0,1 mo
l ) and (Example 1) 2.8 g of 32 can be obtained by almost the same operation as in Example 2. Nuclear magnetic resonance spectrum (DMSO-d6) δ (P P m): 2.0
5(2H,i) 2.45(3)1. s) 2.56~
2.88(4)1. 5.60 (IH, s) 7
.. 25 (2H, d.
J=8.0) 8.05(2H,d、yJ=8.0)〈
実施例5〉
(追 32
p−ニトロフェニルアセトニトリルはメタノールにあま
り溶けないが、1当量のメタノールに懸濁した状態で1
当量以上の塩化水素ガスを吸収させ、−晩、冷蔵庫に放
置することにより定量的に、イミド酸メチル塩酸塩を合
成できた。J = 8.0) 8.05 (2H, d, yJ = 8.0)
Example 5> (Additional 32 p-Nitrophenylacetonitrile is not very soluble in methanol, but when suspended in 1 equivalent of methanol, 1
Methyl imidate hydrochloride could be quantitatively synthesized by absorbing more than an equivalent amount of hydrogen chloride gas and leaving it in the refrigerator overnight.
このイミド酸メチル塩酸塩23g(0,1■ol)と5
−アミノ−3−メチルピラゾール9.7g(0,1■o
l)とから〈実施例1〉 〈実施例2〉とほぼ同様の操
作で32を2.8g得ることができた。融点〜251”
0(分解)23 g (0.1 ol) of this methyl imide hydrochloride and 5
-Amino-3-methylpyrazole 9.7g (0,1■o
1), 2.8 g of 32 could be obtained in substantially the same manner as in Example 1 and Example 2. Melting point ~251"
0 (decomposition)
Claims (4)
の、アルキル又はアリール基を示す。) で表わされる化合物を酸化縮合反応させ、一般式 (式中、R及びR2は前記と同じ意味をもつ。) で表6される化合物を得ることを特徴とするピラゾロ[
工、5−b]、[t、2.4] トリアゾール誘導体の
製造方法。(1) A compound represented by the general formula (in the formula, R and R2 represent a hydrogen atom or a substituted or unsubstituted alkyl or aryl group) is subjected to an oxidative condensation reaction, and the compound represented by the general formula (in the formula, R and R2 has the same meaning as above.) Pyrazolo[
5-b], [t, 2.4] Method for producing a triazole derivative.
換の、アルキル又はアリール基を示す。) で表わされる化合物が、一般式 (式中、R2は前記と同じ意味をもつ。)で表わされる
アミノピラゾールと、一般式(式中、Rは前記と同じ意
味をもち、R3はアルキル基を辰す。) で表わされるイミドエステルとを反応させてイ1#られ
る特許請求の範囲第1項記載のピラゾロ[1,5−bコ
[1,2,4])リアゾール誘導体の製造方法。(2) A compound represented by the general formula (wherein R1 and R2 represent a hydrogen atom or a substituted or unsubstituted alkyl or aryl group) is a compound represented by the general formula (wherein R2 has the same meaning as above). ) and an imide ester represented by the general formula (wherein R has the same meaning as above and R3 represents an alkyl group). A method for producing a pyrazolo[1,5-bco[1,2,4])lyazole derivative according to Scope 1.
の、アルキル又はアリール基を示す。) で表わされる化合物が、一般式 (式中、R1及びR2は前記と同じ意味をもち、R3は
アルキル基である。) で表わされる化合物を塩化アンモニウムと反応させるこ
とにより得られる特許請求の範囲第1項記載のピラゾロ
[1,5,−bl [1,2,4]トリアゾ一ル誘導体
の製造方法。(3) A compound represented by the general formula (wherein R and R2 represent a hydrogen atom or a substituted or unsubstituted alkyl or aryl group) is a compound represented by the general formula (wherein R1 and R2 are as defined above) have the same meaning, and R3 is an alkyl group.) Pyrazolo[1,5,-bl[1,2,4 ] Method for producing a triazol derivative.
の、アルキル又はアリール基を示す。) で表わされる化合物にカップリング離脱基を導入して、
一般式 (式中、Xはカップリング離脱基を示し、R1及びR2
は前記と同じ意味をもつ。) で表わされる化合物を得る特許請求の範囲第1項記載の
ピラゾロ[1,5−bl [1,2,4]トリアゾ一ル
誘導体の製造方法。(4) Introducing a coupling-off group into a compound represented by the general formula (wherein R and R2 represent a hydrogen atom or a substituted or unsubstituted alkyl or aryl group),
General formula (wherein, X represents a coupling-off group, R1 and R2
has the same meaning as above. ) A method for producing a pyrazolo[1,5-bl[1,2,4]triazolyl derivative according to claim 1, which obtains a compound represented by:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7014684A JPS60215687A (en) | 1984-04-10 | 1984-04-10 | Production of pyrazolo(1,5-b)(1,2,4)triazole derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7014684A JPS60215687A (en) | 1984-04-10 | 1984-04-10 | Production of pyrazolo(1,5-b)(1,2,4)triazole derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60215687A true JPS60215687A (en) | 1985-10-29 |
| JPH0479351B2 JPH0479351B2 (en) | 1992-12-15 |
Family
ID=13423140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7014684A Granted JPS60215687A (en) | 1984-04-10 | 1984-04-10 | Production of pyrazolo(1,5-b)(1,2,4)triazole derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60215687A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6210069A (en) * | 1985-07-05 | 1987-01-19 | Konishiroku Photo Ind Co Ltd | 5-amino-1h-pyrazole based compound |
| US5262542A (en) * | 1992-02-26 | 1993-11-16 | Eastman Kodak Company | Process for preparation of 1H-pyrazolo [1,5-b][1,2,4]triazole compounds by cyclization of N-(4-substituted-pyrazolyl)amidoxime |
| US5510492A (en) * | 1992-02-26 | 1996-04-23 | Eastman Kodak Company | Process of preparing pyrazolo 1,5-b! 1,2,4! triazoles |
| EP0711804A2 (en) | 1994-11-14 | 1996-05-15 | Ciba-Geigy Ag | Latent light stabilizers |
-
1984
- 1984-04-10 JP JP7014684A patent/JPS60215687A/en active Granted
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6210069A (en) * | 1985-07-05 | 1987-01-19 | Konishiroku Photo Ind Co Ltd | 5-amino-1h-pyrazole based compound |
| US5262542A (en) * | 1992-02-26 | 1993-11-16 | Eastman Kodak Company | Process for preparation of 1H-pyrazolo [1,5-b][1,2,4]triazole compounds by cyclization of N-(4-substituted-pyrazolyl)amidoxime |
| US5510492A (en) * | 1992-02-26 | 1996-04-23 | Eastman Kodak Company | Process of preparing pyrazolo 1,5-b! 1,2,4! triazoles |
| EP0711804A2 (en) | 1994-11-14 | 1996-05-15 | Ciba-Geigy Ag | Latent light stabilizers |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0479351B2 (en) | 1992-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4621046A (en) | Pyrazolo(1,5-B)-1,2,4-triazole derivatives | |
| EP0322003B1 (en) | Azomethine dye derived from a compound having a pyrazolo triazole moiety | |
| US4705863A (en) | Process for producing pyrazolo[1,5-b][1,2,4]triazole derivatives | |
| JPS60190779A (en) | Preparation of pyrazolo(1,5-b)(1,2,4)triazole derivative | |
| US5110941A (en) | Methods of producing 1H-pyraolo(5,1-c)-1,2,4-triazoles and pyrazole derivatives | |
| JPH0479351B2 (en) | ||
| JP2660775B2 (en) | Method for producing pyrazoloazoles | |
| JPH05186469A (en) | Production of pyrazolo(1,5-b) (1,2,4)triazole-based photographic coupler | |
| JPH05186470A (en) | Production of pyrazolo(1,5-b) (1,2,4)triazole-based photographic coupler | |
| JP2002069071A (en) | 5-sulfonylaminomethyl-1h-pyrrolo-[1,2-b][1,2,4]triazole compound and 5-acylaminomethyl-1h-pyrrolo-[1,2- b][1,2,4]triazole compound | |
| JP3014226B2 (en) | Method for producing pyrazoloazoles | |
| JP2547634B2 (en) | Process for producing 2-acyl-2-aryloxy or heterocyclic oxyacetonitriles and aminopyrazoles | |
| JPH069636A (en) | Production of 1h-pyrazolo(1,5-b)(1,2,4)triazole compound by cyclization of n-(4-substituted pyrazolyl)amidoxime | |
| JP4402220B2 (en) | 1H-pyrrolo- [1,2-b] [1,2,4] triazole derivatives and intermediates thereof | |
| US5248786A (en) | Process for preparation of 1H-pyrazolo [1,5-b][1,2,4]triazole couplers and intermediate compounds | |
| US5510492A (en) | Process of preparing pyrazolo 1,5-b! 1,2,4! triazoles | |
| JP2000086661A (en) | 1h-pyrrolo-[1,2-b][1,2,4]triazole derivative and its production | |
| JP2892772B2 (en) | Method for producing acid amide compound having pyrazoloazole skeleton or pyrazolone skeleton | |
| JPH0566386B2 (en) | ||
| JPH06179679A (en) | Production of 7-aryloxy-1h-pyrazolo(1,5-b)-1,2,4-triazoles | |
| US5395968A (en) | Intermediates and process for preparing magenta couplers | |
| JPH0959250A (en) | Production of compound having aromatic 5-membered ring structure containing nitrogen using 1,3-dihalo-5,5-dimethylhydantoin | |
| JP2000086662A (en) | Production of 1h-pyrrolo-[1,2-b][1,2,4]triazole derivative | |
| JPH0753511A (en) | Production of beta-alkoxycarbonylpyrrole compound | |
| JP2000044563A (en) | Production of 1h-pyrrolo-[1,2-b][1,2,4]triazole compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |